Calcitonin gene-related peptide antagonists in pregnancy: a disproportionality analysis in VigiBase

Background Current evidence on the safety of calcitonin gene–related peptide antagonists (CGRP-A) in pregnancy for the treatment of both episodic and chronic migraine is scarce and does not yet provide definitive information. By querying VigiBase ® , the World Health Organization global pharmacovigi...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	Journal of headache and pain Ročník 25; číslo 1; s. 10 - 6
Hlavní autori:	Noseda, Roberta, Bedussi, Francesca, Gobbi, Claudio, Ceschi, Alessandro, Zecca, Chiara
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	Milan Springer Milan 19.01.2024 Springer Nature B.V BMC
Predmet:	Antagonists Brief Report Calcitonin Calcitonin gene-related peptide Calcitonin gene–related peptide antagonists Disproportionality Headache Internal Medicine Medicine Medicine & Public Health Migraine Neonates Neurology Pain Medicine Peptides Pharmacovigilance Pregnancy Safety VigiBase Pregnancy Disproportionality Safety VigiBase Calcitonin gene–related peptide antagonists
ISSN:	1129-2377, 1129-2369, 1129-2377
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Buďte prvý, kto okomentuje tento záznam!